Search company, investor...
Qu Biologics company logo

Qu Biologics

Founded Year



Grant - III | Alive

Total Raised


About Qu Biologics

Qu Biologics develops Site Specific Immunomodulators (SSI) that aim to restore the body's normal immune response. It stimulates an immune response in targeted organs or tissues to potentially reverse the chronic inflammation underlying many conditions including cancer and immune-related disease. The company was founded in 2007 and is based in Burnaby, Canada.

Headquarters Location

4475 Wayburne Drive Suite 305

Burnaby, British Columbia, V5G 4X4,



Missing: Qu Biologics's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Qu Biologics's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Qu Biologics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Qu Biologics is included in 3 Expert Collections, including Cancer.



4,784 items

Pharmaceutical and biotechnology companies with cancer therapy drug candidates.


Biopharma Tech

15,535 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.


Regenerative Medicine

1,818 items

Regenerative medicine refers to the process of activating, replacing, engineering or regenerating human genetic material, cells, tissues or organs to restore normal function. It also includes bioengineered tissues used for in vitro testing (e.g. organ-on-a-chip, organoids).

Qu Biologics Patents

Qu Biologics has filed 20 patents.

The 3 most popular patent topics include:

  • Immunology
  • Clusters of differentiation
  • Immune system
patents chart

Application Date

Grant Date


Related Topics




Immune system, Clusters of differentiation, Cytokines, Immunology, Transcription factors


Application Date


Grant Date



Related Topics

Immune system, Clusters of differentiation, Cytokines, Immunology, Transcription factors



Latest Qu Biologics News

Microbiome Global Market Report 2023: Featuring Ferring Pharmaceuticals, MRM Health, Second Genome, Qu Biologics & More -

Apr 28, 2023

DUBLIN--(BUSINESS WIRE)--The "Microbiome - Competitive landscape, 2023" report has been added to's offering. This "Microbiome- Competitive landscape, 2023" report provides comprehensive insights about 130+ companies and 180+ drugs in Microbiome Competitive landscape. It covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Report Highlights In April 2023, A

Qu Biologics Frequently Asked Questions (FAQ)

  • When was Qu Biologics founded?

    Qu Biologics was founded in 2007.

  • Where is Qu Biologics's headquarters?

    Qu Biologics's headquarters is located at 4475 Wayburne Drive, Burnaby.

  • What is Qu Biologics's latest funding round?

    Qu Biologics's latest funding round is Grant - III.

  • How much did Qu Biologics raise?

    Qu Biologics raised a total of $25.89M.

  • Who are the investors of Qu Biologics?

    Investors of Qu Biologics include Industrial Research Assistance Program, National Research Council Canada and Genome British Columbia.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.